Resultats globals: 9 registres trobats en 0.02 segons.
Articles, 8 registres trobats
Documents de recerca, 1 registres trobats
Articles 8 registres trobats  
1.
21 p, 2.1 MB The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells : a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes / Cuyàs, Elisabet (Institut d'Investigació Biomèdica (Girona)) ; Gumuzio, Juan (StemTek Therapeutics (Bilbao)) ; Verdura, Sara (Institut d'Investigació Biomèdica (Girona)) ; Brunet, Joan (Institut d'Investigació Biomèdica (Girona)) ; Bosch-Barrera, Joaquim (Universitat de Girona. Departament de Medicina) ; Martin-Castillo, Begoña (Institut Català d'Oncologia) ; Alarcón Cor, Tomás (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Encinar, José Antonio (Universidad Miguel Hernández. Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria (Elche)) ; Martin, Ángel G. (StemTek Therapeutics (Bilbao)) ; Menendez, Javier A. (Institut d'Investigació Biomèdica (Girona))
SOX2 is a core pluripotency-associated transcription factor causally related to cancer initiation, aggressiveness, and drug resistance by driving the self-renewal and seeding capacity of cancer stem cells (CSC). [...]
2020 - 10.18632/aging.102887
Aging (Albany NY), Vol. 12, Issue 6 (March 2020) , p. 4794-4814  
2.
11 p, 2.0 MB In silico clinical trials for anti-aging therapies / Menendez, Javier A. (Institut d'Investigació Biomèdica (Girona)) ; Cuyàs, Elisabet (Institut d'Investigació Biomèdica (Girona)) ; Folguera Blasco, Núria (The Francis Crick Institute. Quantitative Cell Biology Lab) ; Verdura, Sara (Institut d'Investigació Biomèdica (Girona)) ; Martin-Castillo, Begoña (Institut Català d'Oncologia) ; Joven, Jorge (Institut d'Investigació Sanitària Pere Virgili) ; Alarcón Cor, Tomás (Universitat Autònoma de Barcelona. Departament de Matemàtiques)
Therapeutic strategies targeting the hallmarks of aging can be broadly grouped into four categories, namely systemic (blood) factors, metabolic manipulation (diet regimens and dietary restriction mimetics), suppression of cellular senescence (senolytics), and cellular reprogramming, which likely have common characteristics and mechanisms of action. [...]
2019 - 10.18632/aging.102180
Aging (Albany NY), Vol. 11, Issue 16 (August 2019) , p. 6591-6601  
3.
27 p, 3.0 MB A multiscale model of epigenetic heterogeneity-driven cell fate decision-making / Folguera Blasco, Núria (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Pérez Carrasco, Rubén (University College London. Department of Mathematics) ; Cuyàs, Elisabet (Institut d'Investigació Biomèdica (Girona)) ; Menendez, Javier A. (Institut d'Investigació Biomèdica (Girona)) ; Alarcón Cor, Tomás (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Universitat Autònoma de Barcelona. Centre de Recerca Matemàtica
The inherent capacity of somatic cells to switch their phenotypic status in response to damage stimuli in vivo might have a pivotal role in ageing and cancer. However, how the entryexit mechanisms of phenotype reprogramming are established remains poorly understood. [...]
2019 - 10.1371/journal.pcbi.1006592
PLoS computational biology, Vol. 15, Issue 4 (April 2019) , art. e1006592  
4.
19 p, 13.4 MB Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis : evidence for metformin-based "starvation" strategies in BRCA1 carriers / Cuyàs, Elisabet (Institut d'Investigació Biomèdica (Girona)) ; Fernández-Arroyo, Salvador (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Alarcón Cor, Tomás (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Joven, Jorge (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Menendez, Javier A. (Institut d'Investigació Biomèdica (Girona))
We hypothesized that women inheriting one germline mutation of the BRCA1 gene ("one-hit") undergo cell-type-specific metabolic reprogramming that supports the high biosynthetic requirements of breast epithelial cells to progress to a fully malignant phenotype. [...]
2016 - 10.18632/oncotarget.9732
Oncotarget, Vol. 7 (may 2016) , p. 52974-52992  
5.
18 p, 8.3 MB Suppression of endogenous lipogenesis induces reversion of the malignant phenotype and normalized differentiation in breast cancer / Gonzalez-Guerrico, Anatilde M. (Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA) ; Espinoza, Ingrid (Department of Biochemistry, University of Mississippi Medical Center, Jackson, MS, USA) ; Schroeder, Barbara (Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA) ; Park, Cheol Hong (Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA) ; Chandra Mohan, KVP (Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA) ; Khurana, Ashwani (Department of Laboratory Medicine and Pathology, Division of Experimental Pathology, Mayo Clinic, Rochester, MN, USA) ; Corominas-Faja, Bruna (Institut d'Investigació Biomèdica (Girona)) ; Cuyàs, Elisabet (Institut d'Investigació Biomèdica (Girona)) ; Alarcón Cor, Tomás (Universitat Autònoma de Barcelona. Departament de Matemàtiques) ; Kleer, Celina (Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA) ; Menendez, Javier A. (Institut d'Investigació Biomèdica (Girona)) ; Lupu, Ruth (Mayo Clinic Cancer Center, Rochester, MN, USA)
The correction of specific signaling defects can reverse the oncogenic phenotype of tumor cells by acting in a dominant manner over the cancer genome. Unfortunately, there have been very few successful attempts at identifying the primary cues that could redirect malignant tissues to a normal phenotype. [...]
2016 - 10.18632/oncotarget.9463
Oncotarget, Vol. 7 (may 2016) , p. 71151-71168  
6.
13 p, 3.9 MB Accelerated geroncogenesis in hereditary breast-ovarian cancer syndrome / Menendez, Javier A. (Institut d'Investigació Biomèdica (Girona)) ; Folguera Blasco, Núria (Centre de Recerca Matemàtica) ; Cuyàs Navarro, Elisabet (Institut d'Investigació Biomèdica (Girona)) ; Fernández-Arroyo, Salvador (Hospital Universitari de Sant Joan) ; Joven, Jorge (Hospital Universitari de Sant Joan) ; Alarcón Cor, Tomás (Universitat Autònoma de Barcelona. Departament de Matemàtiques)
The geroncogenesis hypothesis postulates that the decline in metabolic cellular health that occurs naturally with aging drives a "field effect" predisposing normal tissues for cancer development. We propose that mutations in the cancer susceptibility genes BRCA1/2 might trigger "accelerated geroncogenesis" in breast and ovarian epithelia. [...]
2016 - 10.18632/oncotarget.7867
Oncotarget, Vol. 7, issue 11 (March 2016) , p. 11959-11971  
7.
11 p, 2.4 MB Oncometabolic nuclear reprogramming of cancer stemness / Menendez, Javier A. (Institut Català d'Oncologia) ; Corominas-Faja, Bruna (Institut d'Investigació Biomèdica (Girona)) ; Cuyàs, Elisabet (Institut d'Investigació Biomèdica (Girona)) ; García, María G. (Instituto Universitario de Oncología del Principado de Asturias) ; Fernández-Arroyo, Salvador (Hospital Universitari de Sant Joan) ; Fernández, Agustín F. (Instituto Universitario de Oncología del Principado de Asturias) ; Joven, Jorge (Hospital Universitari de Sant Joan) ; Fraga, Mario F. (Instituto Universitario de Oncología del Principado de Asturias) ; Alarcón Cor, Tomás (Centre de Recerca Matemàtica)
By impairing histone demethylation and locking cells into a reprogramming-prone state, oncometabolites can partially mimic the process of induced pluripotent stem cell generation. Using a systems biology approach, combining mathematical modeling, computation, and proof-of-concept studies with live cells, we found that an oncometabolite-driven pathological version of nuclear reprogramming increases the speed and efficiency of dedifferentiating committed epithelial cells into stem-like states with only a minimal core of stemness transcription factors. [...]
2016 - 10.1016/j.stemcr.2015.12.012
Stem cell reports, Vol. 6, issue 3 (March 2016) , p. 273-283  
8.
4 p, 1.6 MB Metabostemness : metaboloepigenetic reprogramming of cancer stem-cell functions / Menendez, Javier A. (Institut Català d'Oncologia) ; Corominas-Faja, Bruna (Institut Català d'Oncologia) ; Cuyàs Navarro, Elisabet (Institut Català d'Oncologia) ; Alarcón Cor, Tomás (Centre de Recerca Matemàtica)
Cancer researchers are currently embarking on one of their field's biggest challenges, namely the understanding of how cellular metabolism or certain classes of elite metabolites (e. g. , oncometabolites) can directly influence chromatin structure and the functioning of epi-transcriptional circuits to causally drive tumour formation. [...]
2014 - 10.18632/oncoscience.113
Oncoscience, Vol. 1 (Dec. 2014) , p. 803-806  

Documents de recerca 1 registres trobats  
1.
120 p, 1.9 MB Identificacion y validacion de una firma de expresion de 21 proteinas predictiva en el cancer gastrico mediante tecnicas oncoproteomicas basadas en micromatrices de anticuerpos / Puig Costa, Manuel ; Menéndez Menéndez, Javier Abel, dir. ; Armengol Carrasco, Manuel, dir. ; Codina Cazador, Antonio, dir. ; Universitat Autònoma de Barcelona. Departament de Cirurgia
Objetivo: La detección temprana del cáncer gástrico (CG) es crucial para el tratamiento y supervivencia del paciente. Sin embargo, la adherencia a programas de cribado del CG con los actuales métodos de screening es extremadamente baja. [...]
Purpose: The early detection of gastric cancer (GC) is crucial for successful treatment and patient survival. However, compliance with current screening methods remains poor. This study aimed to identify and validate an accurate a tissue-based protein expression signature for GC detection using low-cost affinity proteomics. [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2014  

Vegeu també: autors amb noms similars
13 Menéndez, Javier A.
1 Menéndez, José Carlos
1 Menéndez, Jésica
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.